Clinical Trials Logo

Filter by:
NCT ID: NCT00790790 Completed - Clinical trials for Osteoarthritis Knee Pain

A Study in the Treatment of Osteoarthritis Knee Pain

Start date: November 2008
Phase: Phase 2
Study type: Interventional

To gather data on whether a new drug for osteoarthritis knee pain will be safe and have an effect on pain levels.

NCT ID: NCT00790192 Completed - Schizophrenia Clinical Trials

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

PEARL 3
Start date: October 2008
Phase: Phase 3
Study type: Interventional

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.

NCT ID: NCT00789854 Completed - Clinical trials for Major Depressive Disorder

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

RUBY
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the efficacy of Quetiapine extended release (XR) in combination with an selective serotonin reuptake inhibitor (SSRI) or Venlafaxine versus Lithium in combination with an selective serotonin reuptake inhibitor or Venlafaxine versus Quetiapine extended release monotherapy in subjects with treatment resistant depression as assessed by the changes from randomisation to week 6 in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score. As an independent objective, the primary objective will also be evaluated in two subgroups of patients: (1) patients who were resistant to two previous antidepressant therapies and (2) in the subgroup of patients with one previous failure.

NCT ID: NCT00789698 Completed - Clinical trials for Chronic Schizophrenia

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

PEARL 3 Ext
Start date: December 2008
Phase: Phase 3
Study type: Interventional

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR long term among schizophrenic outpatients with chronic schizophrenia.

NCT ID: NCT00789633 Completed - Pancreatic Cancer Clinical Trials

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Start date: November 25, 2008
Phase: Phase 3
Study type: Interventional

The objective of this study is to compare the efficacy and safety of masitinib in combination with gemcitabine to placebo in combination with gemcitabine in patients with advanced/metastatic pancreatic cancer.

NCT ID: NCT00789373 Completed - Clinical trials for Non-Small Cell Lung Cancer

A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer

Start date: November 2008
Phase: Phase 3
Study type: Interventional

This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be randomized 2:1 to receive either maintenance pemetrexed or placebo.

NCT ID: NCT00789035 Completed - Clinical trials for Diabetes Mellitus, Type 2

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Start date: October 2008
Phase: Phase 2
Study type: Interventional

The objective is to investigate the efficacy, safety and pharmacokinetics of three different doses of BI 10773 compared to placebo given for 12 weeks in patients with type 2 diabetes mellitus with insufficient glycemic control. In addition an open-label metformin arm will be assessed

NCT ID: NCT00785928 Completed - Clinical trials for Rheumatoid Arthritis

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

Start date: October 2008
Phase: Phase 2
Study type: Interventional

To assess the efficacy of LY2127399 versus placebo using American College of Rheumatology (ACR)50 response scale at 24 weeks

NCT ID: NCT00785785 Completed - Clinical trials for Gastrointestinal Stromal Tumor (GIST)

A Study of Nilotinib Versus Imatinib in GIST Patients

ENESTg1
Start date: March 2009
Phase: Phase 3
Study type: Interventional

This study will evaluate efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).

NCT ID: NCT00785733 Completed - Clinical trials for Moderate/Severe Asthma

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

Start date: November 2008
Phase: N/A
Study type: Observational

The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period